Overview

Epidural Analgesia Use in Pancreatic Resections

Status:
Completed
Trial end date:
2020-02-07
Target enrollment:
Participant gender:
Summary
The rationale for this study is to investigate the benefits of epidural analgesia in pancreatic resections in a prospective, single blind, randomized control trial. This study will evaluate both short and long-term outcomes related to epidural analgesia, providing a longitudinal and comprehensive perspective to the advantages and disadvantages of this technique. The investigators hypothesize that the use of epidural analgesia reduces a patient's consumption of morphine or morphine-equivalent in the post-operative period following pancreatic resections.
Phase:
Phase 1
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
Bupivacaine